The Hemophilia Foundation of Oregon serves as an active force to enhance the quality of life for the genetic bleeding disorders community through advocacy, support, outreach, education, research and promotion of excellence in medical care.

RSS Google News

  • Docs Test New Hemophilia Treatments - WTAJ December 17, 2014
    WTAJDocs Test New Hemophilia TreatmentsWTAJ20,000 Americans are living with hemophilia, a condition that prevents the blood from clotting easily after a cut or injury. Patients are also more susceptible to internal bleeding – which can damage joints, organs and tissue. Researchers are now ...
  • Bayer Submits BLA for Investigational Hemophilia A Drug - Monthly Prescribing Reference December 17, 2014
    Virtual Press OfficeBayer Submits BLA for Investigational Hemophilia A DrugMonthly Prescribing ReferenceBayer Healthcare announced that it has submitted a Biologics License Application (BLA) to the Food and Drug Administration (FDA) for BAY 81-8973, a recombinant Factor VIII (rFVIII) compound, for the treatment of hemophilia A in children and adults.Bayer Su […]